These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 25975054)

  • 1. Studies on the active constituents in radix salviae miltiorrhizae and their protective effects on cerebral ischemia reperfusion injury and its mechanism.
    Li YH; Wang FY; Feng CQ; Yang XF
    Pharmacogn Mag; 2015; 11(41):69-73. PubMed ID: 25709213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA.
    Hu X; Zhang J; Deng L; Hu H; Hu J; Zheng G
    AAPS PharmSciTech; 2021 Mar; 22(3):96. PubMed ID: 33694067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Determination of Four Tanshinones by UPLC-TQ/MS and Their Pharmacokinetic Application after Administration of Single Ethanol Extract of Danshen Combined with Water Extract in Normal and Adenine-Induced Chronic Renal Failure Rats.
    Cai HD; Su SL; Li Y; Zhu Z; Guo J; Zhu Y; Guo S; Qian D; Duan J
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27916808
    [No Abstract]   [Full Text] [Related]  

  • 4. High performance liquid chromatography-mass spectrometry analysis for rat metabolism and pharmacokinetic studies of lithospermic acid B from danshen.
    Cui L; Chan W; Wu JL; Jiang ZH; Chan K; Cai Z
    Talanta; 2008 May; 75(4):1002-7. PubMed ID: 18585175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of borneol on the pharmacokinetics and brain distribution of tanshinone IIA, salvianolic acid B and ginsenoside Rg
    Zhang J; Liu SL; Wang H; Shi LY; Li JP; Jia LJ; Xie BP
    Chin J Nat Med; 2021 Feb; 19(2):153-160. PubMed ID: 33641786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of six phenolic constituents of Danshen injection in rat plasma by LC-ESI-MS and its application to a pharmacokinetic study.
    Zhao D; Han DE; Li N; Lu Y; Li TT; Yang SY; He JK; Chen XJ
    Eur J Mass Spectrom (Chichester); 2011; 17(4):395-403. PubMed ID: 22006631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of quantitative retention-activity relationships between pharmacokinetic parameters and biological effectiveness fingerprints of Salvia miltiorrhiza constituents using biopartitioning and microemulsion high-performance liquid chromatography.
    Gao H; Huang H; Zheng A; Yu N; Li N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1067():10-17. PubMed ID: 28985481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 13 active components in a rat model of middle cerebral artery occlusion after intravenous injection of Radix Salviae miltiorrhizae-Lignum dalbergiae odoriferae prescription.
    Shi B; Li Q; Feng Y; Dai X; Zhao R; Zhao Y; Jia P; Wang S; Yu J; Liao S; Li YF; Zheng X
    J Sep Sci; 2020 Jan; 43(2):531-546. PubMed ID: 31654547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen).
    Li YG; Song L; Liu M; Hu ZB; Wang ZT
    J Chromatogr A; 2009 Mar; 1216(11):1941-53. PubMed ID: 19159889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of tanshinones, the natural products from Salvia miltiorrhiza.
    Wang X; Yang Y; Liu X; Gao X
    Adv Pharmacol; 2020; 87():43-70. PubMed ID: 32089238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic investigation on interaction between hydrophilic lithospermic acid B and lipophilic tanshinone IIA in rats: an experi- mental study.
    Xiuli W; Wei G; Mao S
    J Tradit Chin Med; 2015 Apr; 35(2):206-10. PubMed ID: 25975054
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.